Open AccessP1298: THE IRAK‐4 INHIBITOR EMAVUSERTIB (CA‐4948) FOR THE TREATMENT OF PRIMARY CNS LYMPHOMA
Author(s) -
Von Roemeling C.,
Iqbal M.,
Doonan B.,
HoangMinh L.,
Klippel K.,
Tun H.,
Mitchell D.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000848056.06353.f1
Subject(s) - medicine , primary central nervous system lymphoma , lymphoma , oncology , biomarker , cancer research , biology , biochemistry